- Home
- MS^Q vs LFMDP Comparison
MS^Q vs LFMDP Comparison
Compare MS^Q & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
MS^Q
Morgan Stanley Depositary Shares each representing 1/1000th of a share of 6.625% Non-Cumulative Preferred Stock Series Q
Current Price
Company Overview
Basic Information| Metric | MS^Q | LFMDP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | MS^Q | LFMDP |
|---|---|---|
| Price | N/A | $23.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 1.8K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | N/A | $18.50 |
| 52 Week High | N/A | $24.20 |
Technical Indicators
Market Signals| Indicator | MS^Q | LFMDP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.94 |
| Support Level | N/A | $23.20 |
| Resistance Level | N/A | $23.54 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 50.94 |
Price Performance
Historical ComparisonAbout LFMDP LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.